Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Plos Biology|May 1, 2009
Structural and functional analyses of PAS domain interactions of the clock proteins Drosophila PERIOD and mouse PERIOD2Sven Hennig, Holger M Strauss, Katja Vanselow, et al.
Cureus|January 6, 2025
Bayesian Estimation of the Probability of Virologic Failure on Cabotegravir and Rilpivirine Long-Acting in Real LifeSebastian Noe, Anna Ivanova, Farhad Schabaz, et al.
BMC Oral Health|September 23, 2025
Healthy family traditions and personal health assets - salutogenic resources for oral health among young adults in vulnerable communities in South Africa: a qualitative studyMarie Nordström, Ulrika Lindmark, Eva Wolf, et al.
International Journal of STD & AIDS|October 3, 2025
Persistence on dolutegravir-containing two- and three-drug-regimens in clinical practiceHannes Höller, Anna Ivanova, Farhad Schabaz, et al.
Infection|July 4, 2025
Trough concentrations of cabotegravir and rilpivirine and their association with detectable viral load in people with HIV on long-acting treatmentSebastian Noe, Ulrich Seybold, Farhad Schabaz, et al.
Cell|June 11, 2013
Structures of Drosophila cryptochrome and mouse cryptochrome1 provide insight into circadian functionAnna Czarna, Alex Berndt, Hari Raj Singh, et al.
The Plant Journal : for Cell and Molecular Biology|October 11, 2007
Auto-regulation of the circadian slave oscillator component AtGRP7 and regulation of its targets is impaired by a single RNA recognition motif point mutationJan C Schöning, Corinna Streitner, Damian R Page, et al.
British Journal of Haematology|January 17, 2007
Adoptive transfer of syngeneic T cells in HIV-1 discordant twins indicates rapid regulation of T-cell homeostasisChristian Hoffmann, Hans-Juergen Stellbrink, Thomas Dielschneider, et al.
Expert Opinion on Pharmacotherapy|March 23, 2007
Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatmentAndrew Hill, Kiat Ruxrungtham, Mattana Hanvanich, et al.
HIV Research & Clinical Practice|September 20, 2019
Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 studyMiranda Murray, Federico Pulido, Anthony Mills, et al.
Pageof 13